Biotechnology Journal, published by WILEY-V C H VERLAG GMBH, stands at the forefront of biotechnological research and innovation, recognized for its significant contributions to the fields of applied microbiology, molecular medicine, and broader biotechnology. With its ISSN 1860-6768 and E-ISSN 1860-7314, this journal has achieved impressive 2023 quartile rankings, positioning itself in Q1 for both Applied Microbiology and Biotechnology and Medicine (miscellaneous), and Q2 in Molecular Medicine, showcasing its impact and relevance within the scientific community. Based in Germany, the journal aims to disseminate high-quality research that drives advancements in biotechnological applications, fostering a platform for researchers, professionals, and students to engage with cutting-edge developments. With its ongoing commitment to excellence, the Biotechnology Journal is an essential resource for those seeking to stay informed about the latest trends and innovations in biotechnology.

Synthetic Biology, published by Oxford University Press, is a leading open-access journal that has gained recognition since its inception, becoming a pivotal platform in the fields of Agricultural and Biological Sciences, Bioengineering, Biomaterials, Biomedical Engineering, and Biotechnology. With an ISSN of 2397-7000 and consistent contributions from innovative researchers, the journal has established itself as a Q1 journal in Agricultural and Biological Sciences and ranks notably across various engineering disciplines, making it an essential resource for cutting-edge research and interdisciplinary collaboration. Since becoming fully open access in 2016, it has broadened its reach, allowing easy access to groundbreaking findings that drive advancements in synthetic biology and its applications. The journal's commitment to high-quality, peer-reviewed content serves to inspire researchers, professionals, and students alike, fostering a rich academic community dedicated to exploring the complexities of biological systems and their synthetic counterparts.

Synthetic and Systems Biotechnology, published by KEAI PUBLISHING LTD, is a pioneering open-access journal that has made significant contributions to the fields of applied microbiology, biotechnology, biomedical engineering, genetics, and structural biology since its inception in 2016. With an ISSN of 2405-805X, this journal is committed to fostering innovative research and interdisciplinary collaboration, providing a platform for the dissemination of high-quality studies that push the boundaries of scientific knowledge. Recognized for its excellence, it holds prestigious Q1 rankings in both Applied Microbiology and Biotechnology as well as Biomedical Engineering in 2023, alongside notable Q2 rankings in Genetics and Structural Biology. Researchers, professionals, and students alike can access cutting-edge research that explores the dynamic interplay between synthetic biology and systems biology, driving advancements that could reshape health, industry, and environmental sustainability. By operating under an open-access model, Synthetic and Systems Biotechnology ensures that new findings are accessible to a global audience, thereby maximizing the impact and reach of the published work and paving the way for future discoveries.

Cell Systems is an esteemed journal published by CELL PRESS, dedicated to advancing the field of systems biology and its applications in cell biology, histology, and pathology. Since its inception in 2015, it has quickly ascended to a prominent position within the academic community, currently holding a Q1 ranking across multiple categories including Cell Biology, Histology, and Pathology and Forensic Medicine for 2023. With an impressive Scopus ranking—third in Medicine: Pathology and Forensic Medicine, and similarly high standing in Histology—it serves as a key resource for researchers and professionals aiming to explore and disseminate cutting-edge research findings. The journal provides an open-access platform, making it an accessible source of knowledge for students and scholars alike, fostering collaboration and innovation within the dynamic landscape of cellular research. With a commitment to high-quality and impactful publications, Cell Systems plays a pivotal role in shaping the future of biological sciences.

ENGINEERING IN LIFE SCIENCES, published by Wiley, is a pivotal journal for professionals, researchers, and students dedicated to advancing the interdisciplinary fields of bioengineering, biotechnology, and environmental engineering. With an ISSN of 1618-0240 and an E-ISSN of 1618-2863, this journal has established itself as a reputable platform for disseminating innovative research findings and breakthroughs in engineering applications within the life sciences. Currently holding a prestigious Q2 ranking in multiple categories, including bioengineering and environmental engineering, it reflects a strong commitment to high-quality, impactful research (Scopus ranks: Environmental Science - Rank #61/197, Biochemistry, Genetics and Molecular Biology - Rank #112/311). The journal spans contributions from 2004 to 2024, ensuring a comprehensive archiving of evolving scientific discourse. Although it does not currently offer open access, its curated articles are accessible through institutional and single-article purchases, providing valuable insights and updates for the academic community. Join us in shaping the future of engineering within life sciences and stay informed on critical advancements that are driving innovation across multiple disciplines.

Applied Microbiology and Biotechnology, an esteemed journal published by Springer, serves as a vital resource in the domains of microbiology and biotechnology. With an impressive impact factor reflecting its quality, the journal holds Q1 rankings in various categories including Applied Microbiology and Biotechnology, Biotechnology, and Medicine (Miscellaneous) as of 2023. Spanning the years from 1984 to 2024, it underscores its commitment to disseminating groundbreaking research that addresses pressing challenges in health, agriculture, and environmental sustainability. The journal is rigorously indexed and holds respectable positions in Scopus rankings, notably within the top 15% of Applied Microbiology and Biotechnology and the top 15% in Biochemistry, Genetics, and Molecular Biology. Although it is not Open Access, its comprehensive articles, reviews, and short communications are indispensable for researchers, professionals, and students eager to advance their understanding and application of microbial processes and biotechnological innovations in real-world contexts.

Microbial Cell Factories is a premier peer-reviewed journal dedicated to the field of applied microbiology and biotechnology, published by BMC in the United Kingdom since 2002. With an impressive impact factor, this journal has consistently ranked within the Q1 category across multiple disciplines, including Applied Microbiology, Bioengineering, and Biotechnology, showcasing its significance in the scientific community. The journal’s commitment to open access ensures that innovative research is freely available to researchers, professionals, and students worldwide, fostering collaboration and knowledge dissemination. With a strong presence in Scopus rankings, Microbial Cell Factories is recognized for its contributions to advancing the understanding and application of microbial processes in production systems, making it an essential resource for those involved in the microbiological and biotechnological fields.

New Biotechnology, published by Elsevier, is a distinguished academic journal focused on the innovative realms of biotechnology and bioengineering. With an impact factor reflecting its strong presence in the field, this journal serves as a vital resource for researchers and professionals in the life sciences, offering insights into cutting-edge advancements and applications in biotechnology, molecular biology, and related disciplines. The journal's open access policy enhances its accessibility, allowing broad dissemination of knowledge and research findings. With a robust set of Scopus ranks placing it in the top tiers of its categories, including rank #36 in Biotechnology and #24 in Bioengineering, New Biotechnology represents a critical platform for scholars aiming to contribute to the ongoing dialogue in these rapidly evolving fields. Since its inception in 2008 and continuing through to 2024, the journal remains committed to fostering innovation and collaboration among scientists dedicated to advancing biotechnological applications, thereby significantly impacting medicine and industry.

BIOPROCESS AND BIOSYSTEMS ENGINEERING is a prestigious journal published by Springer, dedicated to advancing the field of bioengineering and biotechnology. Established in 1996, this influential journal provides a platform for disseminating high-quality research that covers a wide spectrum of topics related to bioprocessing, biosystems, and their applications in medicine and environmental engineering. With an impressive impact factor and ranking in the top quartile (Q2) across bioengineering, biotechnology, and miscellaneous medical fields, BIOPROCESS AND BIOSYSTEMS ENGINEERING stands out as a critical resource for researchers, professionals, and students. The journal is indexed in Scopus, reflecting its significant contribution to the scientific community, particularly with its robust percentile rankings (77th in Biotechnology and 70th in Bioengineering). Available in both print and electronic formats, this journal ensures accessible research for those pushing the boundaries of knowledge in bioprocessing and biosystems. As it continues to evolve, BIOPROCESS AND BIOSYSTEMS ENGINEERING encourages submissions that contribute to innovative research practices and applications, thereby fostering academic collaboration and advancement in this dynamic field.

BIOINFORMATICS, published by Oxford University Press, is a leading journal in the realms of biochemistry, computational mathematics, and computer science, with a notable impact factor that underscores its significance in the field. Since its inception in 1985 and continuing through its expected convergence in 2024, the journal has maintained a prestigious reputation, proudly residing in the Q1 category across multiple disciplines, including molecular biology and statistics. With a Scopus ranking placing it within the top percentiles of its categories, BIOINFORMATICS serves as an essential platform for disseminating high-quality research that advances knowledge and innovation at the intersection of biology and computational sciences. This journal not only offers both subscription and open access options, ensuring wider availability of its cutting-edge research, but it has also become a crucial resource for researchers, professionals, and students aiming to stay at the forefront of bioinformatics and related fields. Explore the latest findings and trends that define the future of biological research through this esteemed publication, any inquiries regarding the journal can be directed to its offices located at Great Clarendon St, Oxford OX2 6DP, England.